{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,15]],"date-time":"2026-11-15T06:53:51Z","timestamp":1794725631628,"version":"4.9.1"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"1","funder":[{"name":"Hellenic Institute for the Study of Sepsis"},{"DOI":"10.13039\/501100012112","name":"Swedish Orphan Biovitrum","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100012112","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Med"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1186\/s12916-017-0930-5","type":"journal-article","created":{"date-parts":[[2017,9,15]],"date-time":"2017-09-15T09:01:05Z","timestamp":1505466065000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":198,"title":["Macrophage activation-like syndrome: an immunological entity associated with rapid progression to death in sepsis"],"prefix":"10.1186","volume":"15","author":[{"name":"on behalf of the Hellenic Sepsis Study Group","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evdoxia","family":"Kyriazopoulou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Konstantinos","family":"Leventogiannis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Norrby-Teglund","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georgios","family":"Dimopoulos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aikaterini","family":"Pantazi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stylianos E.","family":"Orfanos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikoletta","family":"Rovina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iraklis","family":"Tsangaris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Theologia","family":"Gkavogianni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elektra","family":"Botsa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eleftheria","family":"Chassiou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anastasia","family":"Kotanidou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christina","family":"Kontouli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Panagiotis","family":"Chaloulis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dimitrios","family":"Velissaris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Athina","family":"Savva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonas-Sund\u00e9n","family":"Cullberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karolina","family":"Akinosoglou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charalambos","family":"Gogos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Apostolos","family":"Armaganidis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evangelos J.","family":"Giamarellos-Bourboulis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,9,18]]},"reference":[{"key":"930_CR1","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1001\/jama.2016.0287","volume":"315","author":"M Singer","year":"2016","unstructured":"Singer M, Deutschman CS, Seymour CW, Shankar-Hari M, Annane D, Bauer M, et al. The third international consensus definitions for sepsis and septic shock (Sepsis-3). JAMA. 2016;315:801\u201310.","journal-title":"JAMA."},{"key":"930_CR2","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1097\/00003246-199206000-00025","volume":"20","author":"American College of Chest Physicians\/Society of Critical Care Medicine Consensus Conference Committee","year":"1992","unstructured":"American College of Chest Physicians\/Society of Critical Care Medicine Consensus Conference Committee. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Crit Care Med. 1992;20:864\u201374.","journal-title":"Crit Care Med"},{"key":"930_CR3","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/S1473-3099(13)70001-X","volume":"13","author":"RS Hotchkiss","year":"2013","unstructured":"Hotchkiss RS, Monneret G, Payen D. Immunosuppression in sepsis: a novel understanding of the disorder and a new therapeutic approach. Lancet Infect Dis. 2013;13:260\u20138.","journal-title":"Lancet Infect Dis."},{"key":"930_CR4","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1097\/00003246-199707000-00010","volume":"25","author":"SM Opal","year":"1997","unstructured":"Opal SM, Fisher Jr CJ, Dhainaut JF, Vincent JL, Brase R, Lowry SF, et al. Confirmatory interleukin-1 receptor antagonist trial in severe sepsis: a phase III, randomized, double-blind, placebo-controlled, multicenter trial. Crit Care Med. 1997;25:1115\u201324.","journal-title":"Crit Care Med."},{"key":"930_CR5","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1097\/CCM.0000000000001402","volume":"44","author":"B Shakoory","year":"2016","unstructured":"Shakoory B, Carcillo JA, Chatham WW, Amdur RL, Zhao H, Dinarello CA, et al. Interleukin-1 receptor blockade is associated with reduced mortality in sepsis patients with features of macrophage activation syndrome: reanalysis of a prior phase III trial. Crit Care Med. 2016;44:275\u201381.","journal-title":"Crit Care Med."},{"key":"930_CR6","doi-asserted-by":"crossref","first-page":"3160","DOI":"10.1002\/art.38802","volume":"66","author":"F Minoia","year":"2014","unstructured":"Minoia F, Dav\u00ec S, Horne A, Demirkaya E, Bovis F, Li C, et al. Clinical features, treatment, and outcome of macrophage activation syndrome complicating systemic juvenile idiopathic arthritis: a multinational, multicenter study of 362 patients. Arthritis Rheumatol. 2014;66:3160\u20139.","journal-title":"Arthritis Rheumatol."},{"key":"930_CR7","doi-asserted-by":"crossref","first-page":"3483","DOI":"10.1182\/blood-2005-05-1980","volume":"106","author":"K Mazodier","year":"2005","unstructured":"Mazodier K, Marin V, Novick D, Farnarier C, Robitail S, Schleinitz N, et al. Severe imbalance of IL-18\/IL-18BP in patients with secondary hemophagocytic syndrome. Blood. 2005;106:3483\u20139.","journal-title":"Blood."},{"key":"930_CR8","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1111\/bjh.13837","volume":"172","author":"AM Schram","year":"2016","unstructured":"Schram AM, Comstock P, Campo M, Gorovets D, Mullally A, Bodio K, et al. Haemophagocytic lymphohistiocytosis in adults: a multicentre case series over 7\u00a0years. Br J Haematol. 2016;172:412\u20139.","journal-title":"Br J Haematol."},{"key":"930_CR9","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1136\/annrheumdis-2015-208982","volume":"75","author":"A Ravelli","year":"2016","unstructured":"Ravelli A, Minoia F, Davi S, Horne AC, Bovis F, Pistorio A, et al. 2016 Classification criteria for macrophage activation syndrome complicating systemic juvenile idiopathic arthritis. A European League Against Rheumatism\/American College of Rheumatology\/Paediatric Rheumatology International Trials Organisation Collaborative Initiative. Ann Rheum Dis. 2016;75:481\u20139.","journal-title":"Ann Rheum Dis"},{"key":"930_CR10","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.1097\/01.CCM.0000168253.91200.83","volume":"33","author":"T Calandra","year":"2005","unstructured":"Calandra T, Cohen J. The international sepsis forum consensus conference on definitions of infection in the intensive care unit. Crit Care Med. 2005;33:1538\u201348.","journal-title":"Crit Care Med."},{"key":"930_CR11","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1097\/01.CCM.0000155991.88802.4D","volume":"33","author":"J Sund\u00e9n-Cullberg","year":"2005","unstructured":"Sund\u00e9n-Cullberg J, Norrby-Teglund A, Rouhiainen A, Rauvala H, Herman G, Tracey KJ, et al. Persistent elevation of high mobility group box-1 protein (HMGB1) in patients with severe sepsis and septic shock. Crit Care Med. 2005;33:564\u201373.","journal-title":"Crit Care Med."},{"key":"930_CR12","doi-asserted-by":"crossref","first-page":"1536","DOI":"10.1097\/01.CCM.0000266536.14736.03","volume":"35","author":"J Sund\u00e9n-Cullberg","year":"2007","unstructured":"Sund\u00e9n-Cullberg J, Nystr\u00f6m T, Lee ML, Mullins GE, Tokics L, Andersson J, et al. Pronounced elevation of resistin correlates with severity of disease in severe sepsis and septic shock. Crit Care Med. 2007;35:1536\u201342.","journal-title":"Crit Care Med."},{"key":"930_CR13","doi-asserted-by":"crossref","first-page":"R90","DOI":"10.1186\/cc11353","volume":"16","author":"A Linder","year":"2012","unstructured":"Linder A, Akesson P, Inghammar M, Treutiger CJ, Linner A, Sunden-Cullberg J. Elevated plasma levels of heparin-binding protein in intensive care unit patients with severe sepsis and septic shock. Crit Care. 2012;16:R90.","journal-title":"Crit Care."},{"key":"930_CR14","doi-asserted-by":"crossref","first-page":"R149","DOI":"10.1186\/cc11463","volume":"16","author":"EJ Giamarellos-Bourboulis","year":"2012","unstructured":"Giamarellos-Bourboulis EJ, Norrby-Teglund A, Mylona V, Savva A, Tsangaris I, Dimopoulou I, et al. Risk assessment in sepsis: a new prognostication rule by APACHE II score and serum soluble urokinase plasminogen activator receptor. Crit Care. 2012;16:R149.","journal-title":"Crit Care."},{"key":"930_CR15","doi-asserted-by":"crossref","first-page":"2613","DOI":"10.1002\/art.38690","volume":"66","author":"L Fardet","year":"2014","unstructured":"Fardet L, Galicier L, Lambotte O, Marzac C, Aumont C, Chahwan D, et al. Development and validation of the HScore, a score for the diagnosis of reactive hemophagocytic syndrome. Arthritis Rheumatol. 2014;66:2613\u201320.","journal-title":"Arthritis Rheumatol."},{"key":"930_CR16","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1055\/s-0037-1616068","volume":"86","author":"FB Taylor","year":"2001","unstructured":"Taylor FB, Toh CH, Hoots WK, Wada H, Levi M. Towards definition, clinical and laboratory criteria, and a scoring system for disseminated intravascular coagulation. Thromb Haemost. 2001;86:1327\u201330.","journal-title":"Thromb Haemost."},{"key":"930_CR17","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.cmi.2016.11.003","volume":"23","author":"EJ Giamarellos-Bourboulis","year":"2017","unstructured":"Giamarellos-Bourboulis EJ, Tsaganos T, Tsangaris I, Lada M, Routsi C, Sinapidis D, et al. Validation of the new sepsis-3 definitions: proposal for improvement in early risk identification. Clin Microbiol Infect. 2017;23:104\u20139.","journal-title":"Clin Microbiol Infect."},{"key":"930_CR18","doi-asserted-by":"crossref","first-page":"2101","DOI":"10.1002\/pbc.25058","volume":"61","author":"K Lehmberg","year":"2014","unstructured":"Lehmberg K, McClain KL, Janka GE, Allen CE. Determination of an appropriate cut-off value for ferritin in the diagnosis of hemophagocytic lymphohistiocytosis. Pediatr Blood Cancer. 2014;61:2101\u20133.","journal-title":"Pediatr Blood Cancer."},{"key":"930_CR19","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.semarthrit.2014.09.004","volume":"44","author":"M Kostik","year":"2015","unstructured":"Kostik M, Dubko M, Masalova V, Snegireva L, Kornishina T, Chikova I, et al. Identification of the best cut off points and clinical signs specific for early recognition of macrophage activation syndrome in active systemic juvenile idiopathic arthritis. Semir Arthr Rheum. 2015;44:417\u201322.","journal-title":"Semir Arthr Rheum."},{"key":"930_CR20","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1146\/annurev.immunol.021908.132715","volume":"27","author":"F Martinon","year":"2009","unstructured":"Martinon F, Mayor A, Tschopp J. The inflammasomes: guardians of the body. Annu Rev Immunol. 2009;27:229\u201365.","journal-title":"Annu Rev Immunol."},{"key":"930_CR21","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1186\/1741-7015-11-185","volume":"11","author":"C Ros\u00e1rio","year":"2013","unstructured":"Ros\u00e1rio C, Zandman-Goddard G, Meyron-Holtz EG, D\u2019Cruz DP, Shoenfeld Y. The hyperferritinemic syndrome: macrophage activation syndrome, Still\u2019s disease, septic shock and catastrophic antiphospholipid syndrome. BMC Med. 2013;11:185.","journal-title":"BMC Med."},{"key":"930_CR22","first-page":"289","volume":"4","author":"C Dinarello","year":"2013","unstructured":"Dinarello C, Novick D, Kim S, Kaplanski G. Interleukin-18 and IL-18 binding protein. Front Immunol. 2013;4:289.","journal-title":"Front Immunol."},{"key":"930_CR23","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1086\/315214","volume":"181","author":"CA Gogos","year":"2000","unstructured":"Gogos CA, Drosou E, Bassaris HP, Skoutelis A. Pro- versus anti-inflammatory cytokine profile in patients with severe sepsis: a marker for prognosis and future therapeutic options. J Infect Dis. 2000;181:176\u201380.","journal-title":"J Infect Dis."},{"key":"930_CR24","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.imlet.2004.07.009","volume":"95","author":"G Monneret","year":"2004","unstructured":"Monneret G, Finck ME, Venet F, Debard AL, Boh\u00e9 J, Bienvenu J, Lepape A. The anti-inflammatory response dominates after septic shock: association of low monocyte HLA-DR expression and high interleukin-10 concentration. Immunol Lett. 2004;95:193\u20138.","journal-title":"Immunol Lett."},{"key":"930_CR25","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.it.2011.03.007","volume":"32","author":"G Cairo","year":"2011","unstructured":"Cairo G, Recalcati S, Mantovani A, Locati M. Iron trafficking and metabolism in macrophages: contribution to the polarized phenotype. Trends Immunol. 2011;32:241\u20137.","journal-title":"Trends Immunol."},{"key":"930_CR26","first-page":"662","volume":"16","author":"S Colafrancesco","year":"2014","unstructured":"Colafrancesco S, Priori R, Alessandri C, Astorri E, Perricone C, Blank M, et al. The hyperferritinemic syndromes and CD163: a marker of macrophage activation. Isr Med Assoc J. 2014;16:662\u20133.","journal-title":"Isr Med Assoc J."}],"container-title":["BMC Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12916-017-0930-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,18]],"date-time":"2020-05-18T03:36:52Z","timestamp":1589773012000},"score":1,"resource":{"primary":{"URL":"http:\/\/bmcmedicine.biomedcentral.com\/articles\/10.1186\/s12916-017-0930-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,9,18]]},"references-count":26,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["930"],"URL":"https:\/\/doi.org\/10.1186\/s12916-017-0930-5","relation":{},"ISSN":["1741-7015"],"issn-type":[{"value":"1741-7015","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,9,18]]},"article-number":"172"}}